Packaging & Drug Delivery

Wednesday 19 May

19 MAY 2021

Packaging & Drug Delivery

PANEL - ON DEMAND

The COVID-19 Cold Chain – Delivering Vaccines to the Masses

While the initial challenge was in developing effective therapies against COVID-19, the next hurdles are manufacturing at scale, drug delivery solutions, cool chain and logistics. How is the industry responding?

Discussion points

COVID-19 Update: The 2021 Vaccine Line Up
Facility challenges & manufacturing at scale
Drug Delivery solutions – what are the options aside from glass vials?
Key supply chain challenges for vaccine products
Creating sustainable and resilient distribution systems
Challenges in allocating and prioritizing vaccine supplies and distribution

Marie-Liesse Le Corfec, Global Head of Portfolio Marketing, BD Medical Pharmaceutical Systems

Sponsored by BD

19 MAY 2021

LIVE PANEL - 15:00-16:00 CET

Drug Delivery Start-Ups to Watch in 2021 and Beyond

As the pharmaceutical industry continues to grow and drug complexity increases, drug delivery devices must adapt accordingly.

Device manufacturers are increasingly looking to start-ups to identify novel technologies and innovative products that are not only patient-friendly and cost-effective, but also differentiators in a competitive market.

This session will feature start-ups providing novel technologies and innovative solutions to current challenges in the drug delivery technology landscape. And it will tackle some on the main trends and challenges ahead for this industry.

Discussion points

Promising start-ups in the drug delivery space driving patient adherence and innovation
Partnering strategies for Pharma companies and innovators
R&D vs M&A
A look into the future of drug delivery: regulation, capital raising, and investments

Moderator: Wayne Weiner, Principal, Pharmatech Solutions LLC
Mahmoud Ameri, VP Research & Development at Zosano Pharma
Don Zinn, VP US Business. Crossject
José Ochoa Chief Business Officer, Altimmune, Inc.

19 MAY 2021

PRESENTATION - ON DEMAND

Crystal Clear - The Rise of Pharmaceutical Glass Packaging Solutions

Glass primary packaging solutions offer safety, stability, recyclability and protect drug integrity. The glass packaging market is predicted to grow exponentially in the next few years, driven in part by the huge demand for glass vials for COVID-19 vaccines.

Discussion points

What are the emerging trends in this sector?
Unprecedented demands: the impact of COVID-19 on the glass packaging market
What are the limitations with glass products?
Smart Containers: A new vision for Pharma Packaging?
Growing demand - which are the biggest and emerging markets for glass packaging solutions?

Daniel, Martinez, Product Manager for Syringes, Components & SG Lab, Stevanato Group
Yasemin Bettina Karanis. Consultant, Thought Leadership, IQVIA

19 MAY 2021

CPHI WEBINAR SERIES - REPURPOSED CONTENT

Track & Trace Solutions for Direct-to-Patient Delivery

Building a comprehensive track-and-trace system for medicines, which aligns with the European Falsified Medicines Directive and ensures compliance is a must in today’s environment.

Pharmacies, hospitals, HCPs, carers and patients now expect a completely secure and traceable delivery process, which requires buy-in from pharmaceutical companies and distributors. This session provides an overview of the key trends and developments to improve the security of direct-2-patient drug delivery in 2021.

Discussion points

A global overview of regulations on traceability of medical devices and medicines
Technical challenges when tracking medicinal products along the product life cycle, from clinical trials to post-marketing authorization
What does the future look like? The potential of delivering Direct-to-Patient unique doses

Sponsored by Stevanato Group

CPHI WEBINAR SERIES - REPURPOSED CONTENT

Driving Digital Transformation in Pharma

Increased adoption of digital technologies can provide many benefits to pharma innovators – from data optimization and analysis to increase productivity in R&D, to sourcing candidates for clinical trials.

While there are still several obstacles to achieving a full digital transformation, pharma companies are taking up digital change by anticipating the healthcare industry's unique challenges.

Discussion points:

What can digitalization do for Pharma innovators?
How has the Covid-19 pandemic accelerated digital innovation in the pharma industry?
Partnering for success – how engaging with start-ups and tech companies can help acquire expertise and accelerate development
A review of successful solutions and initiatives

Sponsored by Stevanato Group

CPHI WEBINAR SERIES - REPURPOSED CONTENT

Trends in Auto-Injectors – Early Considerations for Emergency Use Auto-Injector Development and Manufacturing

The global auto-injector market is expected to witness a CAGR of 17.9% from 2020 to 2025. Market growth is largely driven by the growing prevalence of targeted therapies, a shift towards self-administration and technological advancements.

This session will provide an overview of the factors driving growth in the auto-injector space, examining evolving technologies for safer, more efficient and patient-friendly emergency auto-injector platforms.

Discussion Points:

Overview of the auto-injector market and emergency-use application. What’s driving growth?
What’s new in primary packaging materials for auto-injection platforms?
Designing the user experience of emergency auto-injectors
Developing auto-injectors for mechanical reliability and customizability

Adam Stops, Drug Delivery Systems Product Manager, Stevanato Group
Yasemin Bettina Karanis. Consultant, Thought Leadership at IQVIA

Daniel MacDonald, Vice President Engineering, Duoject Medical Systems

PRESENTATION - ON DEMAND

19 MAY 2021

Patient-Centric Drug Delivery Solutions for Self-Administration

The need to reduce health care costs, improve outcomes, and increase access to remote care are intensifying the focus on patient care delivery in the home setting.

As a result, pharma is seeking alternate delivery systems that can provide patient autonomy and mobility while delivering treatment outside of the clinic. Programmable, variable dose on-body injectors provide such options.

This talk will highlight considerations for on-body injectors to promote drug delivery in non-clinical settings.

Christian Sandmann, R&D Associate Director, BD Medical Pharmaceutical Systems

Intranasal Immunization: Promises and Challenges

Nasal spray drug delivery can prvide significant advantages over traditional approaches to vaccine administration. In this session, hear from Aptar Pharma and Vaccine Market Review on nasal physiology and Vaccine targets.

Discussion Points:

Overview of intranasal formulation
Market opportunties for nasal vaccines
Aptar Pharma device offerings

Speakers

Dr Julie Suman, President Next Breath, an Aptar Pharma company
Nektaria Karavas, Director of Business Development, Aptar Pharma

Sponsored by BD

Sponsored by Aptar Pharma

PRESENTATION - ON DEMAND

The Need for Ready-To-Administer Solutions in Acute Care

Several factors motivate pharmaceutical companies and hospitals to use glass prefillable syringes (PFS) for Intravenous (IV) applications. By switching from vials and ampules to a glass PFS, hospitals have the potential to reduce medical errors, improve workflow efficiency and impact ROI for hospital stakeholders.

Moreover, data suggests that approximately 92% of hospital stakeholders are willing to use prefilled syringes for multiple drugs.

For pharmaceutical companies, transitioning a fixed-dose drug from its vial or ampule format to a prefilled syringe can serve as a differentiation strategy in a market dominated by vials and ampules.

This session will examine the benefits and challenges associated with glass formats, and will explore BD’s glass prefillable syringe with connection performance verified for IV applications.

Sagar Bejalwar, Global Portfolio Lead - Acute care & Specialty, BD Medical Pharmaceutical Systems

LEARNING LAB - ON DEMAND

UniSafe – Bringing safety devices into the 21st century

Introduction to Owen Mumford Pharma Services, a global leader in drug delivery systems.

Discussion points:

• Business Development Team Introduction
• Addressing future market trends for injectable drug delivery
• UniSafe 1 mL-a Spring-Free passive safety device for pre-filled syringes

Sian Eden, Business Development Manager, Owen Mumford Pharmaceutical Services

Olivia Houselander, Business Development Manager, Owen Mumford Pharmaceutical Services

Sponsored by Owen Mumford Pharmaceutical Services